Literature DB >> 25921545

Nutrition and physical activity on hypertension: implication of current evidence and guidelines.

Iran Castro, Gustavo Waclawovsky, Aline Marcadenti1.   

Abstract

Hypertension (HTN) is the leading cause of worldwide mortality and is responsible for approximately 40% of deaths from cardiovascular disease, chronicle kidney disease (CKD) and type 2 diabetes mellitus (T2DM) according to the World Health Organization (WHO). It is known that about 80% of all mortality from cardiovascular disorders could be prevented if a healthy diet and higher levels of physical activity were included among general population's lifestyle. Besides, guidelines for the treatment and control of HTN were recently modified for adequate nutritional and physical activity recommendations highlighted in meta-analysis and strong evidences such as randomized clinical trials. Therefore, to discuss nutrition and physical activity in the context of HTN seems to be crucial.

Entities:  

Mesh:

Year:  2015        PMID: 25921545     DOI: 10.2174/1573402111666150429170302

Source DB:  PubMed          Journal:  Curr Hypertens Rev        ISSN: 1573-4021


  9 in total

1.  Factors associated with not adopting healthy behavior among hypertensive individuals: a population-based study in Brazil.

Authors:  Franciele A V Dionato; Carla C Enes; Luciana B Nucci
Journal:  J Hum Hypertens       Date:  2020-07-27       Impact factor: 3.012

2.  Prevalence and Associated Risk Factors of Hypertension in Adults with Disabilities: A Cross-Sectional Study in Shanghai, China.

Authors:  Hengjing Wu; Jing Wu; Ziyan Zhang; Yongtao Zheng; Wenxin Niu; Liang Zheng; Jue Li
Journal:  Clin Epidemiol       Date:  2021-08-27       Impact factor: 4.790

3.  How can counselling by family physicians on nutrition and physical activity be improved: trends from a survey in Germany.

Authors:  S J Boesenecker; V Mathies; J Buentzel; J Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-06       Impact factor: 4.322

4.  Physical Activity, Obesity, and Hypertension among Adults in a Rapidly Urbanised City.

Authors:  Qianqian Dun; Wanglin Xu; Maozhen Fu; Nengjian Wu; Justin B Moore; Ting Yu; Xin Li; Yating Du; Biao Zhang; Qiaomai Wang; Yiting Duan; Ziqi Meng; Shuangshuang Tian; Yuliang Zou
Journal:  Int J Hypertens       Date:  2021-08-11       Impact factor: 2.420

5.  Knowledge, attitude and practices of lifestyle modification and associated factors among hypertensive patients on-treatment follow up at Yekatit 12 General Hospital in the largest city of East Africa: A prospective cross-sectional study.

Authors:  Taye Kebede; Zaid Taddese; Abiot Girma
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

6.  Testing the efficacy of a couple-focused, tailored eHealth intervention for symptom self-management among men with prostate cancer and their partners: the study protocol.

Authors:  Lixin Song; Matthew E Nielsen; Ronald C Chen; Christine Rini; Thomas C Keyserling; Eno Idiagbonya; Gail P Fuller; Laurel Northouse; Mary H Palmer; Xianming Tan
Journal:  Trials       Date:  2022-01-04       Impact factor: 2.279

7.  Association between physical activity dimensions and the risk of hypertension among middle and older adults: A cross-sectional study in China.

Authors:  Linlin Zhou; Wei Feng; Na Xiang; Yue Cheng; Xudong Ya; Mingxia Wang; Xingqi Wang; Yujia Liu
Journal:  Front Public Health       Date:  2022-09-24

Review 8.  The effects of chromium supplementation on blood pressure: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Mahtab Ghanbari; Mohammad Reza Amini; Kurosh Djafarian; Sakineh Shab-Bidar
Journal:  Eur J Clin Nutr       Date:  2021-07-23       Impact factor: 4.016

9.  An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: A cross-sectional analysis.

Authors:  Takeshi Endo; Kenju Akai; Tsunetaka Kijima; Shigetaka Kitahara; Takafumi Abe; Miwako Takeda; Toru Nabika; Shozo Yano; Minoru Isomura
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.